References
1
Sosnovskikh VYa.
Usachev BI.
Sizov AYu.
Vorontsov II.
Shklyaev YuV.
Org. Lett.
2003,
5:
3123
2
Sosnovskikh VYa.
Usachev BI.
Sizov AYu.
Synthesis
2004,
942
3a
Katsuyama I.
Ogawa S.
Yamaguchi Y.
Funabiki K.
Matsui M.
Muramatsu H.
Shibata K.
Synthesis
1997,
1321
3b
Katsuyama I.
Funabiki K.
Matsui M.
Muramatsu H.
Shibata K.
Synlett
1997,
591
3c
Lee LF.
Stikes GL.
Molyneaux JM.
Sing YL.
Chupp JP.
Woodard SS.
J. Org. Chem.
1990,
55:
2872
3d Lee LF. inventors; Eur. Pat. Appl. EP 0133612.
; Chem. Abstr. 1986, 104, 19514
3e
Xiong W.-N.
Yang C.-G.
Jiang B.
Bioorg. Med. Chem.
2001,
9:
1773
4
Norton DG.
Haury VE.
Davis FC.
Mitchell LJ.
Ballard SA.
J. Org. Chem.
1954,
19:
1054
5
General Procedure for the Synthesis of Anilines(4). A mixture of chromone 1 (15.3 mmol) and imine 2 (33.7 mmol) was refluxed with drying tube for 10 h. Then, the resulting brown liquid was distilled at reduced pressure to give the corresponding aniline 4 as a yellow viscous oil. According to the 1H NMR and 19F NMR spectra, compounds 4a-d contained only 1-3% of the starting chromones 1. Spectral and analytical data for selected products follows.
3′-(Isopropylamino)-5-methyl-5′-(trifluoromethyl)[1,1′-biphenyl]-2-ol (
4b): IR (nujol): 3540, 3400, 1605, 1510
cm-1. 1H NMR (400 MHz, CDCl3/TMS): δ = 1.24 (d, 6 H, 2 CH3, J = 6.3 Hz), 2.31 (s, 3 H, CH3), 3.68 (sept, 1 H, CH, J = 6.3 Hz), 3.80 (br s, 1 H, NH), 4.40-5.50 (br s, 1 H, OH), 6.76-6.78 (m, 2 H, H-2′, H-4′), 6.87 (d, 1 H, H-3,
o
J = 8.1 Hz), 6.95 (sext, 1 H, H-6′, 4
J
H,H = 4
J
H,F = 0.7 Hz), 7.04 (dq, 1 H, H-6,
m
J = 2.2 Hz, 4
J
H,CH3 = 0.6 Hz), 7.07 (ddq, 1 H, H-4,
o
J = 8.1 Hz,
m
J = 2.2 Hz, 4
J
H,CH3 = 0.6 Hz). 19F NMR (376 MHz, CDCl3/C6F6): δ = 98.90 (s, CF3). Anal. Calcd for C17H18F3NO: C, 66.01; H, 5.87; N, 4.53. Found: C, 66.21; H, 5.96; N, 4.39.
3′-(Isopropylamino)-5′-(1,1,2,2-tetrafluoroethyl)[1,1′-biphenyl]-2-ol (
4d): IR (nujol): 3530, 3400, 1605, 1515
cm-1. 1H NMR (400 MHz, CDCl3/TMS): δ = 1.25 (d, 6 H, 2 CH3, J = 6.3 Hz), 3.68 (sept, 1 H, CH, J = 6.3 Hz), 3.80 (br s, 1 H, NH), 5.30 (br s, 1 H, OH), 5.91 (tt, 1 H, CF2CF2H, 2
J
H,F = 54.1 Hz, 3
J
H,F = 2.8 Hz), 6.72-6.76 (m, 2 H, H-2′,
H-4′), 6.88 (s, 1 H, H-6′), 6.96-7.01 (m, 2 H, H-3, H-5), 7.23-7.29 (m, 2 H, H-4, H-6). 19F NMR (376 MHz, CDCl3/C6F6): δ = 27.52 (dt, CF2
CF
2
H, 2
J
F,H = 54.1 Hz, 3
J
F,F = 4.1 Hz), 47.65 (q, CF
2
CF2H, 3
J
F,H = 3
J
F,F ca. 3.6 Hz). Anal. Calcd for C17H17F4NO: C, 62.38; H, 5.23; N, 4.28. Found: C, 62.82; H, 5.54; N, 4.23.
6a
Organofluorine Compounds in Medicinal Chemistry and Biomedical Applications
Filler R.
Kobayashi Y.
Yagupolskii LM.
Elsevier;
Amsterdam:
1993.
6b
Hiyama T.
Organofluorine Compounds. Chemistry and Application
Springer-Verlag;
Berlin:
2000.
7
Andrew RJ.
Mellor JM.
Reid G.
Tetrahedron
2000,
56:
7255
8
Bunnelle WH.
Singam PR.
Narayanan BA.
Bradshaw CW.
Liou JS.
Synthesis
1997,
439